TARA — Protara Therapeutics, Inc. catalysts
Next verified catalyst
2026-12-01 — Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformat · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic
Phase 2 · Lymphatic Malformation |
TARA Protara Therapeutics, Inc. | TARA-002 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|